186 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
total cash proceeds of $187.8 million, net of assets transferred to Sandoz, assets derecognized, transactions costs of $7.2 million and other employee
8-K
EX-99.1
um1io kvxo4v551
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
pkmxiuxk160b
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
8-K
EX-2.1
cj79ms1t6k7g3m7g35
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
f4sicuoa41hb
11 Dec 23
Departure of Directors or Certain Officers
4:13pm
8-K
zyf ts9uq1lo
7 Dec 23
Departure of Directors or Certain Officers
5:16pm
8-K
EX-99.1
hgxic4l8r9r2fet
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm